GENERAL
All reagents were purchased from commercial sources and were used without further purification. Solvents of at least p.a. quality were used. Kryptofix ® 2.2.2 was obtained from Merck, Mannose triflate from ABX. Sep-Pak Accell Plus QMA carbonate, Sep-Pak tC18, Oasis HLB and Sep-Pak Alumina A cartridges were obtained from Waters. Analytical HPLC was done on an Agilent 1200 system using a Luna NH 2 (5 µm, 250 × 4.6 mm, Phenomenex, Germany) column. Radio-TLC was done on a mini-GITA system from Raytest. Water content measurements were performed on a Karl-Fischer pocket titrator (ECH Elektrochemie Halle GmbH, Germany). F]fluoride was trapped on an ion exchange cartridge (QMA carbonate, 46 mg) which was previously preconditioned with water. The QMA was dried by passing through 20 mL of air, followed by rinsing the cartridge with anhydrous MeCN (5 mL) and flushing it again with air (20 mL). The [ 18 F]fluoride was eluted into an Eppendorf vial using the corresponding cryptate solution (500 µL). Mannose triflate (20 mg) was dissolved in MeCN (25 µL) and added to the [ 18 F]fluoride solution. The vial was placed in a heating block and heated for 10 minutes at 90 °C with shaking (400 rpm).
EXPERIMENTAL PROCEDURES

Synthesis of [ 18 F]FDG
No carrier added [ 18 F]fluoride was produced via 18 O(p, n) 18 F reaction by proton irradiation of an 18 Oenriched water target of a PETtrace cyclotron. The [ 18 F]fluoride was trapped on an ion exchange cartridge (QMA carbonate, 10 mg) which was previously preconditioned with water. The QMA was dried by passing through 5 mL of air, followed by rinsing the cartridge with anhydrous MeCN (1 mL) and flushing it again with air (5 mL). The [ 18 F]fluoride was eluted into an Eppendorf vial using [K2.2.2]H 2 PO 4 in tBuOH + 1% H 2 O (300 µL). Mannose triflate (20 mg) was dissolved in MeCN (25 µL) and added to the [ 18 F]fluoride solution. The vial was placed in a heating block and heated for 10 minutes at 90 °C with shaking (400 rpm). The mixture was diluted with H 2 O (5 mL) and passed through a Sep-Pak tC18 cartridge (900 mg). The cartridge was washed with H 2 O (5 mL) and dried with air. Subsequently, the cartridge was wetted with NaOH (2M, 400 µL) to allow the hydrolysis to proceed on solid support. After 3 minutes at ambient temperature, the product was eluted with H 2 O (800 µL) followed by neutralization with H 3 PO 4 (2.29M, 200 µL). The mixture was passed through an Oasis HLB (150 mg) and a Sep-Pak Alumina A cartridge which were finally washed with H 2 O (1 mL) to yield the final [ 18 F]FDG solution. 
TLC AND HPLC ANALYSIS
HPLC analysis of [ 18 F]FDG
A Phenomenex Luna NH 2 column was used (250 × 4.6 mm, 5 µm) with isocratic elution with MeCN / H 2 O 70:30 at a flow rate of 1 mL/min. [ 18 F]FDG is eluted at a retention time of 4.1 min. with a purity > 99%. 
ON-CHIP EXPERIMENTAL
In the first step, a chip layout for the desired process was established utilizing CAD software (SolidWorks, Dassault Systèmes, SolidWorks Corp.). Subsequently, COC 6017-S04 (TOPAS® Advanced Polymers GmbH, Germany) was utilized for injection moulding of rectangular blanks (Rodinger Kunststoff-Technik GmbH, Germany) with outer dimensions of 100mm × 100mm × 2mm. One microfluidic chip (Fig. S3) consists of three separate layers (outer dimensions each 95mm × 60mm × 2mm) and one COC 6015 foil (TOPAS ® 100 Advanced Polymers GmbH, Germany, thickness 100µm). All microfluidic structures on each of the layers are created utilizing a four axis computerized numerical controlled (CNC) milling machine (MDX-540 SA, Roland DGA Corp., USA). After milling, all layers including the foil were cleaned and assembled together and joined in a single thermal bonding step. No additional manufacturing processes are required. The chip is loaded into a control system identical to the one described in prior work (C. Rensch, S. Lindner, R. Salvamoser, S. Leidner, C. Bold, V. Samper, D. Taylor, M. Baller, S. Riese, P. Bartenstein, C. Wängler and B. Wängler, Lab Chip, 2014, 14, 2556) . The miniaturized QMA cartridge (10mg) setup is schematically illustrated in figure S4 and was located external to the microfluidic chip device. However, as illustrated in prior art, the resin could be transferred on-chip (patent application WO/2014066748/A1). MBq) was transferred to a 2 mL starting vial which was connected to the microfluidic platform. The QMA cartridge (10 mg) was preconditioned with 5 mL Tracepur water utilizing a syringe pump of the platform. Subsequently, the [ 18 F]fluoride was transferred from the starting vial to the ion exchange cartridge by means of gas pressure. The QMA was dried by N 2 gas stream at 2 bars for 10 s, followed by rinsing the cartridge with anhydrous MeCN (5 mL, via syringe pump) and flushing it again with nitrogen at 2 bars for 10 s. The [ 18 F]fluoride was eluted into the on-chip reaction chamber using [K2.2.2]H 2 PO 4 in tBuOH + 1% H 2 O (300 µL) which was transferred from a 2 mL low dead volume vial by means of gas pressure. Mannose triflate (20 mg) was dissolved in MeCN (25 µL) and added to the [ 18 F]fluoride solution by transferring it from a low dead volume vial to the on-chip reactor via gas pressure. The on-chip reactor was heated to 90 °C for 10 min to perform the labeling reaction. The on-chip reactor venting valve was open during reagent transfer to the reaction chamber and closed during the reaction to avoid evaporation and loss of activity. After labeling, the product was ejected to the [ 18 F]FTAG vial by means of gas pressure. One chip rinsing step was applied by flushing the reaction chamber with 1 mL of water (from a connected syringe pump) and ejecting the water into the [ 18 F]FTAG vial by means of gas pressure.
